-
Research Services<a class="dhimg1" href="/shichangdetail1/9.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/8926ff01-64bc-4928-a995-396bdb9d8102.jpg" alt="Aniphe BioLab"> </a> <a class="dhimg2" href="/shichangdetail/8.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/26342b34-4f1e-4d28-9166-7b685e6d70c3.jpg" alt="Aniphe BioLab"> </a>
-
Preclinical CRO<a class="dhimg1" href="/shichangdetail/6.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/cc43bac1-07d9-4340-9677-fbe01c51330a.jpg" alt="Aniphe BioLab"> </a> <a class="dhimg2" href="/shichangdetail/10.html" rel="nofollow" target="_self"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/f1d8f739-0d36-4cb8-adeb-26de791d909c.jpg" alt="Aniphe BioLab"> </a>
-
-
-
-
Reproductive system disease model
Aniphe BioLab develops reproductive disease models based on key pathological mechanisms, including hormonal imbalance, abnormal inflammatory responses, tissue remodeling, and local microenvironment dysregulation. These models support in vivo research on endometriosis and ovarian dysfunction.
By reproducing disrupted hormonal cycles, sustained inflammatory cytokine release, and reproductive tissue fibrosis and adhesion formation, our models provide reliable platforms for disease mechanism studies and drug evaluation. Applications include anti-inflammatory and hormonal therapies, reproductive tissue repair, and research on reproductive endocrine regulation and tissue remodeling.
Precision Modeling
System Verification
Repeatability
Accelerate R&D
Related Resources
Characteristics of the Aniphe BioLab Reproductive System Disease Model
In response to the research needs surrounding dysregulation of the reproductive system’s microenvironmental homeostasis and associated histopathological changes, Ailinfei Biotechnology has established a standardized animal model platform for reproductive system diseases, characterized by the following key features:
|
It encompasses common disease models such as endometriosis, pelvic inflammatory disease, ovarian dysfunction, and tubal damage, thereby meeting the needs of basic research on reproductive disorders and drug‑efficacy evaluation. |
Standardize and rigorously control hormone‑induced protocols, local inflammatory stimuli, and tissue transplantation/injury procedures to minimize the impact of individual variability on experimental outcomes. |
By integrating histopathological analysis, hormonal profiling, inflammatory cytokine assessment, and evaluation of reproductive function parameters, a comprehensive determination of both structural and functional status can be achieved. |
Provide raw experimental data, imaging results, and systematic analysis reports to ensure data traceability and compliance with publication and regulatory submission requirements. |
Animal models of reproductive system diseases, by mimicking hormonal dysregulation, local inflammation, and tissue remodeling, provide a stable and reproducible in vivo experimental platform for investigating the pathogenesis of reproductive disorders and for evaluating pharmacological agents and reproductive intervention strategies.
Product List:
Disease Name
Disease model
Details
|
Disease Name |
Disease model |
Construction method |
|
Thin endometrium |
Thin uterine model |
Mechanical curettage |
|
Chronic Cervicitis |
Cervicitis model |
Cervical application of phenol mucilage |
|
Testicular torsion injury |
Testicular ischemia-reperfusion model |
Testicular torsion of 720° |
|
Vasectomy sterilization |
Vasectomy model |
Inguinal incision for vasectomy |
|
Benign prostatic hyperplasia |
Prostatic hyperplasia model |
Combined injection of testosterone and estradiol |
|
Premature Ovarian Insufficiency |
Ovarian Function Decline Model |
Intraperitoneal injection of cyclophosphamide |
|
Pain associated with endometriosis |
Endometriosis pain model |
Autologous graft lesion + behavioral monitoring |
|
Uterine leiomyoma |
Uterine fibroid model |
Subcutaneous implantation of estrogen sustained-release tablets |
Aniphe BioLab Inc.
Address:
Runcheng, No. 8 Longtai Road, Jiangbei New Area, Nanjing City, Jiangsu Province
Building 8, Science Park
Postal Code: 210007
Phone:025-8520 8061
Email:info@aniphebio.com(Consultation)
Email:order@aniphebio.com(Order)
WeChat Official Account
Video Account
Su Public Security Bureau Internet Information Service Filing No. 32010402001421